Relevium RLLVF Stock
Relevium Price Chart
Relevium RLLVF Financial and Trading Overview
| Relevium stock price | 0.0060 USD |
| Previous Close | 0.006 USD |
| Open | 0.22 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.22 - 0.22 USD |
| 52 Week Range | 0.006 - 0.22 USD |
| Volume | 43 USD |
| Avg. Volume | 0 USD |
| Market Cap | 1.98M USD |
| Beta (5Y Monthly) | 1121.996 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
RLLVF Valuation Measures
| Enterprise Value | 775.8K USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.13875571 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 0.054 |
| Enterprise Value/EBITDA | 0.764 |
Trading Information
Relevium Stock Price History
| Beta (5Y Monthly) | 1121.996 |
| 52-Week Change | 0% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 0.22 USD |
| 52 Week Low | 0.006 USD |
| 50-Day Moving Average | 0.006 USD |
| 200-Day Moving Average | 0.006 USD |
RLLVF Share Statistics
| Avg. Volume (3 month) | 0 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 329.49M |
| Float | 318.88M |
| Short Ratio | N/A |
| % Held by Insiders | 3.22% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2021 |
| Most Recent Quarter (mrq) | March 31, 2022 |
| Next Fiscal Year End | June 30, 2022 |
Profitability
| Profit Margin | -18.50% |
| Operating Margin (ttm) | 35.50% |
| Gross Margin | 16.62% |
| EBITDA Margin | 7.12% |
Management Effectiveness
| Return on Assets (ttm) | 4.19% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 14.25M USD |
| Revenue Per Share (ttm) | 0.05 USD |
| Quarterly Revenue Growth (yoy) | 959.39% |
| Gross Profit (ttm) | 2.37M USD |
| EBITDA | 1.02M USD |
| Net Income Avi to Common (ttm) | -2636260 USD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 697.39K USD |
| Total Cash Per Share (mrq) | 0.002 USD |
| Total Debt (mrq) | 1.47M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.595 |
| Book Value Per Share (mrq) | -0.00217422 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 22.05M USD |
| Levered Free Cash Flow (ttm) | -585433 USD |
Profile of Relevium
| Country | United States |
| State | QC |
| City | Montreal |
| Address | 1000 Sherbrooke St. West |
| ZIP | H3A 3G4 |
| Phone | N/A |
| Website | https://www.releviumtechnologies.com |
| Industry | Pharmaceutical Retailers |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Relevium Technologies Inc. engages in the identification, evaluation, acquisition, and operation of brands and businesses in the health and wellness markets with a focus on e-commerce. The company markets dietary supplements, nutraceuticals, sports nutrition products, and cosmeceuticals primarily through its Bioganix brand portfolio online; dietary supplements under the LeefyLyfe brand; and skin care products under the Push & Pull System brand. It also provides Relevium Senior, a geriatric brand targeting inflammatory conditions, including joints, heart, and brain; and Relevium Kids, a pediatric brand of nutraceuticals and oral nutritional supplements. The company was formerly known as BIOflex Technologies Inc. and changed its name to Relevium Technologies Inc. in December 2015. Relevium Technologies Inc. is headquartered in Montreal, Canada.
Q&A For Relevium Stock
What is a current RLLVF stock price?
Relevium RLLVF stock price today per share is 0.0060 USD.
How to purchase Relevium stock?
You can buy RLLVF shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Relevium?
The stock symbol or ticker of Relevium is RLLVF.
Which industry does the Relevium company belong to?
The Relevium industry is Pharmaceutical Retailers.
How many shares does Relevium have in circulation?
The max supply of Relevium shares is 329.49M.
What is Relevium Price to Earnings Ratio (PE Ratio)?
Relevium PE Ratio is now.
What was Relevium earnings per share over the trailing 12 months (TTM)?
Relevium EPS is -0.01 USD over the trailing 12 months.
Which sector does the Relevium company belong to?
The Relevium sector is Healthcare.